Vcreate
Stanford
About Vcreate
Vcreate is in the process of developing the next generation of T-cell immunotherapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $150.0K
- Funding stage: Seed
- Last round: Pre-Seed (Oct 2023)
- Website: vcreate.io
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/vcreate-137456 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.